25063-55-2

Basic information

• Product Name: 2,2-dimethyl-5-{[(3-trifluoromethylphenyl)amino]methylene}-1,3-dioxane-4,6-dione
• Synonyms: 2,2-dimethyl-5-{[(3-trifluoromethylphenyl)amino]methylene}-1,3-dioxane-4,6-dione
• CAS NO: 25063-55-2
• Molecular Weight: 315.249
• Mol File: 25063-55-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2,2-dimethyl-5-{[(3-trifluoromethylphenyl)amino]methylene}-1,3-dioxane-4,6-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-dimethyl-5-{[(3-trifluoromethylphenyl)amino]methylene}-1,3-dioxane-4,6-dione(25063-55-2)
• EPA Substance Registry System: 2,2-dimethyl-5-{[(3-trifluoromethylphenyl)amino]methylene}-1,3-dioxane-4,6-dione(25063-55-2)

Safety Data

• Hazardous Substances Data: 25063-55-2(Hazardous Substances Data)

Upstream product

• 2033-24-1 cycl-isopropylidene malonate 
• 98-16-8 3-trifluoromethylaniline 
• 122-51-0 orthoformic acid triethyl ester 

Downstream Products

• 346-55-4 4-chloro-7-trifluoromethyl quinoline 
• 322-97-4 7-trifluoromethyl-quinolin-4-ol 

Relevant articles and documents

Facile one-pot synthesis, butyrylcholinesterase and α-glucosidase inhibitory activities, structure–activity relationship, molecular docking and DNA–drug binding analysis of Meldrum’s acid derivatives

Meldrum’s acid derivatives were facile synthesized by one-pot condensation process and characterized by NMR (1H, 13C, DEPT-90 and DEPT-135) and EI-MS. The synthesized compounds were screened for their potential to inhibit butyrylcholinesterase (BChE) and α-glucosidase enzymes. Interestingly, the derivative 3a showed potent α-glucosidase inhibitory activity, with the IC50 value equal to 2.1?mg/mL as compared to standard acarbose (IC50 = 4.7?mg/mL), whereas, in terms of BChE inhibitory activity investigation, the derivatives 3a and 3c showed novel results, with the IC50 values equal to 1.2 and 2.9?mg/mL, respectively, as compared to standard galantamine hydrobromide (IC50 = 4.7?mg/mL), making derivative 3a a dual inhibitor of both enzymes. Further, structure–activity relationship, comparative molecular docking analysis and the DNA–drug binding interaction were studied to investigate relationship between the chemical structure and its biological activity, inhibition of mechanism, interaction of compounds, DNA binding constant and Gibbs free energy. Structural insights into inhibitor binding to the α-glucosidase and BuChE revealed significant contribution of hydrophobic regions and significant residues of active sites. Comparative molecular docking studies showed that the residues of oxyanion hole, catalytic triad and hydrophobic pocket were actively engaged in interaction with the inhibitor. DNA binding constant was found in the order Kb 3e > Kb 3c > Kb 3a > Kb 3b > Kb 3d, while Gibbs free energy was found in the order ?G 3e > ?G 3a > ?G 3b > ?G 3c > ?G 3d.